Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-20-000338
Filing Date
2020-06-12
Accepted
2020-06-12 16:07:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 hgen13g.htm SC 13G 65654
  Complete submission text file 0000935836-20-000338.txt   67522
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Subject) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87188 | Film No.: 20960278
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARKET STREET STEUART TOWER SUITE 2625 SAN FRANCISCO CA 94105
Business Address ONE MARKET STREET STEUART TOWER SUITE 2625 SAN FRANCISCO CA 94105 415-659-7217
Valiant Capital Management, L.P. (Filed by) CIK: 0001452689 (see all company filings)

EIN.: 262303018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G